A 35-year-old woman with poorly controlled diabetes presents with oral candidiasis and vaginal thrush. She is started on antifungal therapy. Regarding the pharmacokinetic and clinical properties of antifungals used in mucosal candidiasis, all of the following statements are true EXCEPT:

Explanation

## Antifungals in Mucosal Candidiasis: Pharmacokinetics and Clinical Use ### Overview of Agents **Key Point:** Different antifungals have vastly different bioavailability and tissue penetration profiles, determining their clinical use. | Agent | Class | Bioavailability | CNS Penetration | Clinical Use | |-------|-------|-----------------|-----------------|---------------| | Fluconazole | Azole | Excellent (>90%) | Excellent | Systemic, meningitis, prophylaxis | | Nystatin | Polyene | Poor (not absorbed) | None | Topical, oral candidiasis only | | Miconazole | Azole | **Poor (topical use only)** | Limited | Topical/vaginal, NOT systemic | | Clotrimazole | Azole | Poor (topical) | None | Topical, vaginal, oral lozenges | ### Why Miconazole is the Exception **High-Yield:** Miconazole has **poor oral bioavailability** and is used **only for topical and vaginal applications**, NOT for systemic fungal infections. The option incorrectly states it can be used for "both systemic and topical fungal infections." **Clinical Pearl:** When systemic antifungal therapy is needed for candidiasis, fluconazole is the first-line azole. Miconazole IV is rarely used in modern practice due to poor tolerability and efficacy; it is primarily a topical agent. ### Why the Other Options Are Correct 1. **Fluconazole:** Excellent CSF penetration (60–80% of serum levels) makes it ideal for candidal meningitis and CNS infections [cite:Harrison 21e Ch 256]. 2. **Nystatin:** Polyene antibiotic with negligible absorption — used only for topical/oral candidiasis (swish-and-spit or vaginal creams). 3. **Clotrimazole:** Available as vaginal tablets (100 mg, 500 mg) and is effective first-line therapy for vulvovaginal candidiasis. **Mnemonic: FOAM** **F** = Fluconazole → Fantastic CSF penetration **O** = Oral bioavailability (excellent for systemic use) **A** = Azoles → variable absorption **M** = Miconazole → **Minimal** systemic absorption (topical only) **Warning:** Do not confuse miconazole (topical) with fluconazole (systemic). Both are azoles, but their bioavailability and clinical roles are entirely different.